CN104651531B - Kit for detecting juvenile recurrent respiratory papilloma virus - Google Patents
Kit for detecting juvenile recurrent respiratory papilloma virus Download PDFInfo
- Publication number
- CN104651531B CN104651531B CN201510035254.1A CN201510035254A CN104651531B CN 104651531 B CN104651531 B CN 104651531B CN 201510035254 A CN201510035254 A CN 201510035254A CN 104651531 B CN104651531 B CN 104651531B
- Authority
- CN
- China
- Prior art keywords
- recurrent respiratory
- hpv11
- juvenile
- detecting
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000306 recurrent effect Effects 0.000 title claims abstract description 35
- 206010038707 Respiratory papilloma Diseases 0.000 title claims abstract description 26
- 230000000366 juvenile effect Effects 0.000 title claims abstract description 18
- 241001631646 Papillomaviridae Species 0.000 title claims description 13
- 239000000523 sample Substances 0.000 claims abstract description 27
- 238000012360 testing method Methods 0.000 claims abstract description 7
- 230000003321 amplification Effects 0.000 claims description 19
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 19
- 230000000241 respiratory effect Effects 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 239000013641 positive control Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 239000013642 negative control Substances 0.000 claims description 2
- 238000003757 reverse transcription PCR Methods 0.000 claims description 2
- 238000003149 assay kit Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 25
- 238000003753 real-time PCR Methods 0.000 abstract description 16
- 241000700605 Viruses Species 0.000 abstract description 10
- 238000011841 epidemiological investigation Methods 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 19
- 238000000034 method Methods 0.000 description 8
- 101150075239 L1 gene Proteins 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 241000701806 Human papillomavirus Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 206010003497 Asphyxia Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 241000341655 Human papillomavirus type 16 Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 208000029211 papillomatosis Diseases 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 208000001307 recurrent respiratory papillomatosis Diseases 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 208000006601 tracheal stenosis Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种病毒TapMan荧光定量检测试剂盒,确切讲是一种用于检测青少年复发性呼吸道乳头瘤HPV11亚型一步法TapMan 荧光定量PCR检测试剂盒。 The invention relates to a virus TapMan fluorescent quantitative detection kit, specifically a one-step TapMan fluorescent quantitative PCR detection kit for detecting HPV11 subtypes of adolescent recurrent respiratory papilloma.
背景技术Background technique
青少年复发性呼吸道乳头瘤状瘤(juvenile-onset recurrent respiratorypapilloma,JO-RRP)特指发生于上下呼吸道的乳头瘤病,是一种由乳头瘤状病毒(humanpapillomavirus,HPV)病毒引起的具有高度复发性及侵袭性的疾病,可以发生于呼吸道任何部位,其中最易累积与鳞状上皮与纤毛柱状上皮交界处。JORRP患者首发症状主要是声音嘶哑,首发年龄最小为两周,最大为14周岁,且病程表现多样,个别患儿可以自发缓解,多数则呈现侵润生长并需要多次手术甚至出现喉、气管狭窄梗阻窒息死亡,临床治疗十分棘手。Juvenile-onset recurrent respiratory papilloma (JO-RRP) specifically refers to papillomatosis that occurs in the upper and lower respiratory tracts, and is a highly recurrent disease caused by the human papillomavirus (HPV) virus. And invasive disease, can occur in any part of the respiratory tract, which is most likely to accumulate at the junction of squamous epithelium and ciliated columnar epithelium. The first symptom of JORRP patients is mainly hoarseness. The age of onset is as young as two weeks and as old as 14 years old. The course of the disease is diverse. Some children can relieve spontaneously, but most of them show infiltrating growth and require multiple operations or even larynx and tracheal stenosis Obstruction asphyxiation death, clinical treatment is very difficult.
HPV属于乳多空病毒科的乳头瘤空泡病毒A属,是由8000个碱基组成的环状双链DNA病毒,约有200余中亚型。根据病毒的基因组结构、生物学特性和致病性,可分为五大类,即α、β、γ、μ和ν,低危型的HPV6和HPV11属于α乳头瘤病毒。低危型与青少年复发性呼吸道乳头瘤状瘤密切相关,国内外学者即已开展了相关的治疗研究,然而尚未建立有效的细胞培养模型或简便的病毒繁殖模型,难以进行传统的灭活疫苗或着监督疫苗的研制。HPV belongs to the Papillomavacuovirus A genus of the family Papovaviridae. It is a circular double-stranded DNA virus composed of 8000 bases, and there are about 200 subtypes. According to the genome structure, biological characteristics and pathogenicity of the virus, it can be divided into five categories, namely α, β, γ, μ and ν. The low-risk HPV6 and HPV11 belong to the α papillomavirus. The low-risk type is closely related to adolescent recurrent respiratory papillomatosis. Scholars at home and abroad have carried out related treatment research. However, no effective cell culture model or simple virus reproduction model has been established. It is difficult to carry out traditional inactivated vaccines or monitoring the development of vaccines.
研究认为HPV的亚型与病情严重程度和临床经过相关,而且亚型之间存在毒力差异,因此临床上能够快速区分引起青少年复发性呼吸道乳头瘤状病毒HPV11亚型显得的尤为重要。常规PCR方法检测灵敏度不高,且易出现假阳性,已有的检测性病HPV11亚型的SYBRGreen荧光法属于非饱和染料,不能完全饱和的嵌入DNA双链中,会造成检测结果的不准确。Studies have shown that HPV subtypes are related to disease severity and clinical course, and there are differences in virulence between subtypes. Therefore, it is particularly important to quickly distinguish the HPV11 subtypes that cause recurrent respiratory papillomaviruses in adolescents clinically. The detection sensitivity of conventional PCR method is not high, and it is prone to false positives. The existing SYBRGreen fluorescence method for detecting venereal disease HPV11 subtype is a non-saturated dye, which cannot be fully saturated and embedded in the DNA double strand, which will cause inaccurate detection results.
发明内容Contents of the invention
本发明提供一种对可用于检测青少年复发性呼吸道乳头瘤HPV11亚型的高度特异性引物对及探针,以及包括有这一高度特异性引物对及探针的可特异、敏感、快速和便捷的用于定量检测青少年复发性呼吸道乳头瘤HPV11亚型的试剂盒。The present invention provides a pair of highly specific primers and probes that can be used to detect HPV11 subtypes of recurrent respiratory papilloma in adolescents, as well as a specific, sensitive, rapid and convenient method that includes the highly specific primers and probes. A kit for the quantitative detection of HPV11 subtypes in adolescent recurrent respiratory papilloma.
本发明的用于检测青少年复发性呼吸道乳头瘤状病毒的高度特异性引物对,其序列分别为SEQ ID No.1和 SEQ ID No.2。The sequences of the highly specific primer pair for detecting juvenile recurrent respiratory papillomavirus of the present invention are SEQ ID No.1 and SEQ ID No.2 respectively.
本发明的用于检测青少年复发性呼吸道乳头瘤状病毒的试剂盒内包括的高度特异序列为 SEQ ID No.3的探针。为使用方便,本发明的试剂盒内还有2×One Step RT-PCRBufferⅢ、TaKaRa Ex Taq HS(5U/μL)和PrimeScript RT Enzyme MixⅡ等扩增所需要的所有实验试剂,检测时只需按照说明加入检测样品即可。The highly specific sequence included in the kit for detecting juvenile recurrent respiratory papillomavirus of the present invention is the probe of SEQ ID No.3. For the convenience of use, there are also all experimental reagents needed for amplification such as 2×One Step RT-PCRBuffer III, TaKaRa Ex Taq HS (5U/μL) and PrimeScript RT Enzyme Mix II in the kit of the present invention, and only need to follow the instructions for detection Just add the test sample.
本发明的用于检测青少年复发性呼吸道乳头瘤状病毒的试剂盒内还含有作为阴性对照的不含青少年复发性呼吸道乳头瘤HPV11亚型的DNA样品和作为阳性对照的含有青少年复发性呼吸道乳头瘤HPV11亚型的DNA样品。The kit for detecting juvenile recurrent respiratory papilloma virus of the present invention also contains as a negative control a DNA sample that does not contain the subtype of juvenile recurrent respiratory papilloma HPV11 and as a positive control a DNA sample containing juvenile recurrent respiratory papilloma DNA samples of HPV11 subtype.
前述本发明的引物对优选扩增条件为: 95℃ 10sec,1个循环→95℃ 10sec,55℃30sec,72℃ 30sec,40个循环。The preferred amplification conditions for the aforementioned primer pair of the present invention are: 95° C. for 10 sec, 1 cycle → 95° C. for 10 sec, 55° C. for 30 sec, 72° C. for 30 sec, 40 cycles.
本发明的试剂盒实际上是一种一步法TapMan 荧光定量PCR检测的试剂盒。一步法TapMan 荧光定量PCR检测是使用5`端带有荧光物质,3`端带有淬灭物质的TapMan探针进行荧光检测,当探针完整时,5`端荧光物质受到3`端淬灭物质的制约,不能发出荧光。而当TapMan探针被分解后,5`端的荧光物质便会游离出来,发出荧光。在PCR反应中特异性探针和模板杂交,延伸是聚合酶活性可以分解与模板杂交的荧光探针,游离荧光物质发出荧光。通过检测反应体系中的荧光强度,从而可以达到检测PCR产物扩增量的目的。在PCR使用本试剂盒进行Real Time PCR反应可在同一反应管内连续进行,操作简单,并能有效防止污染。The kit of the present invention is actually a kit for one-step TapMan fluorescent quantitative PCR detection. One-step TapMan fluorescent quantitative PCR detection is to use the TapMan probe with a fluorescent substance at the 5' end and a quenching substance at the 3' end for fluorescence detection. When the probe is intact, the fluorescent substance at the 5' end is quenched by the 3' end Material constraints, can not emit fluorescence. When the TapMan probe is decomposed, the fluorescent substance at the 5' end will dissociate and emit fluorescence. In the PCR reaction, the specific probe and the template hybridize, and the extension is that the polymerase activity can decompose the fluorescent probe hybridized with the template, and the free fluorescent substance emits fluorescence. By detecting the fluorescence intensity in the reaction system, the purpose of detecting the amplification amount of the PCR product can be achieved. Real Time PCR reaction using this kit in PCR can be carried out continuously in the same reaction tube, which is easy to operate and can effectively prevent pollution.
利用本发明试剂盒进行青少年复发性呼吸道乳头瘤HPV11亚型一步法TapMan荧光定量PCR检测,其优点在于,根据青少年复发性呼吸道乳头瘤HPV11亚型流行株的L1基因保守涉及到两条高度特异性引物和探针,在该病毒DNA提取的基础上,对组织样品进行荧光定量PCR扩增,实现对青少年复发性呼吸道乳头瘤HPV11亚型的定量检测。Utilizing the kit of the present invention to detect the HPV11 subtype of adolescent recurrent respiratory papilloma by one-step TapMan fluorescent quantitative PCR detection has the advantage that the L1 gene conservation of the popular strain of HPV11 subtype of adolescent recurrent respiratory papilloma involves two highly specific genes. Primers and probes, on the basis of the DNA extraction of the virus, perform fluorescence quantitative PCR amplification on the tissue samples, and realize the quantitative detection of HPV11 subtypes of adolescent recurrent respiratory papilloma.
本发明用到的TaqMan探针法为针对青少年复发性呼吸道乳头瘤状病毒HPV11亚型特异的核苷酸序列设计的探针,探针与模板是高度特异性结合,特异性和敏感性均高。填补了临床上快速分型检测青少年复发性呼吸道乳头瘤状病毒HPV11亚型的空白。The TaqMan probe method used in the present invention is a probe designed for the specific nucleotide sequence of the adolescent recurrent respiratory papillomavirus HPV11 subtype. The probe is highly specific to the template, and the specificity and sensitivity are high. . It fills the blank of clinical rapid typing detection of recurrent respiratory papillomavirus HPV11 subtype in adolescents.
本发明的试剂盒中有对青少年复发性呼吸道乳头瘤HPV11亚型L1基因序列比对后,根据保守区域优化设计高度特异性引物和探针。在使用本发明的试剂盒进行检测时,是对青少年复发性呼吸道乳头瘤HPV11亚型DNA提取后直接进行定量PCR扩增,同时本发明对反应体系及反应条件进行了优化,使检测PCR扩增一步完成,简化了操作步骤,减少污染几率,并能提高了检测的精准度,一步法TapMan荧光定量在扩增完成后可直接进行标准曲线定量起始病毒拷贝数,同时其操作简单快捷,非常适用于分型检测及该病毒流行病学调查的应用。In the kit of the present invention, highly specific primers and probes are optimally designed according to conserved regions after alignment of the HPV11 subtype L1 gene sequence of adolescent recurrent respiratory papilloma. When the kit of the present invention is used for detection, quantitative PCR amplification is directly carried out after extracting the DNA of adolescent recurrent respiratory papilloma HPV11 subtype, and the present invention optimizes the reaction system and reaction conditions to make detection PCR amplification It is completed in one step, which simplifies the operation steps, reduces the chance of contamination, and improves the accuracy of detection. The one-step TapMan fluorescence quantification can directly perform the standard curve quantification of the initial virus copy number after the amplification is completed. At the same time, its operation is simple and fast, very It is suitable for the application of typing detection and epidemiological investigation of the virus.
附图说明Description of drawings
图1:含青少年复发性呼吸道乳头瘤HPV11亚型L1基因序列重组质粒酶切鉴定电泳图,Figure 1: The electrophoresis diagram of the enzyme digestion identification of the recombinant plasmid containing the HPV11 subtype L1 gene sequence of adolescent recurrent respiratory papilloma,
其中:M:2000bp DNA MarkerAmong them: M: 2000bp DNA Marker
1: 重组质粒pMD-HPV11-L1双酶切鉴定1: Identification of recombinant plasmid pMD-HPV11-L1 by double enzyme digestion
2:重组质粒pMD- HPV11-L1单酶切线性化2: Linearization of the recombinant plasmid pMD-HPV11-L1 by single enzyme digestion
图2:HPV11一步法TapMan 荧光定量PCR的扩增曲线,其中:纵坐标代表荧光量,横坐标代表循环数扩增曲线从左到右表示目的DNA的拷贝数分别为2.59×108-2.59×103;Figure 2: The amplification curve of HPV11 one-step TapMan fluorescent quantitative PCR, where: the ordinate represents the amount of fluorescence, and the abscissa represents the number of cycles. The amplification curve from left to right indicates the copy number of the target DNA is 2.59×10 8 -2.59× 10 3 ;
图3:HPV11病毒一步法TapMan荧光定量PCR检测标准曲线,其中:纵坐标代表Ct值。横坐标代表样品的拷贝数,相关系数R2:0.999,扩增效率Eff:101.1%;Figure 3: One-step TapMan fluorescent quantitative PCR detection standard curve for HPV11 virus, where: the vertical axis represents the Ct value. The abscissa represents the copy number of the sample, the correlation coefficient R2: 0.999, the amplification efficiency Eff: 101.1%;
图4:是检测方法特异性的扩增曲线;Figure 4: is the amplification curve specific to the detection method;
图5:是检测方法敏感性的扩增曲线,其中:纵坐标代表荧光量,横坐标代表循环数,扩增曲线自左到右的DNA的拷贝数分别为1×108-1×101。Figure 5: The amplification curve of the sensitivity of the detection method, where: the ordinate represents the amount of fluorescence, the abscissa represents the number of cycles, and the copy numbers of DNA from left to right in the amplification curve are 1×10 8 -1×10 1 .
具体实施方式detailed description
以下结合具体实例和附图说明对本发明做进一步说明Below in conjunction with specific example and accompanying drawing description, the present invention will be further described
一、青少年复发性呼吸道乳头瘤HPV11亚型荧光定量PCR引物的设计与合成1. Design and synthesis of fluorescent quantitative PCR primers for adolescent recurrent respiratory papilloma HPV11 subtype
利用已知的青少年复发性呼吸道乳头瘤HPV11亚型L1基因序列比对后,根据保守区域利用Primer Express3.0软件设计引物和探针,送宝生物工程(大连)有限公司合成。上下游引物及探针分别为:After alignment of the known HPV11 subtype L1 gene sequence of juvenile recurrent respiratory papilloma, primers and probes were designed using Primer Express 3.0 software according to the conserved region, and synthesized by Songbao Bioengineering (Dalian) Co., Ltd. The upstream and downstream primers and probes are:
SEQ ID No.1:(HPV11-F)5’- TCCTCCTAACCCTGTATC -3’SEQ ID No.1: (HPV11-F) 5'-TCCTCCTAAACCCTGTATC-3'
SEQ ID No.2:(HPV11-R)5’- TGCTGGCATGATAAAATATG -3’SEQ ID No.2: (HPV11-R) 5'-TGCTGGCATGATAAAATATG-3'
SEQ ID No.3:(HPV11-Probe) 5’-CATAAGCATCCGTGGCAACAACTT-3’(5′FAM, 3′TAMRA)SEQ ID No.3: (HPV11-Probe) 5'-CATAAGCATCCGTGGCAACAACTT-3' (5'FAM, 3'TAMRA)
二、标准品的制备2. Preparation of Standards
参考青少年复发性呼吸道乳头瘤HPV11亚型在NCBI上登陆的序列,通过比较分析后,设计出能扩增L1基因的部分序列的上下游引物,送宝生物工程(大连)有限公司合成。上下游引物分别为:Referring to the sequence of HPV11 subtype of juvenile recurrent respiratory papilloma registered on NCBI, after comparative analysis, the upstream and downstream primers that can amplify the partial sequence of L1 gene were designed and synthesized by Songbao Bioengineering (Dalian) Co., Ltd. The upstream and downstream primers are:
SEQ ID No.4:SEQ ID No.4:
(HPV11-5674-F)5’- TGGACGACCAGCTCTTCCTTAAACAC-3’;(HPV11-5674-F) 5'-TGGACGACCAGCTCTTCCTTAAACAC-3';
SEQ ID No.5: SEQ ID No.5:
(HPV11-6807-R)(HPV11-6807-R)
5’-AGTGCAAGTCTGGGTTGCAGCCAACA-3’。5'-AGTGCAAGTCTGGGTTGCAGCCAACA-3'.
取呼吸道乳头瘤组织在生物安全柜中,研磨稀释后,按照Omega DNA提取试剂盒(货号:D3096)说明书提取组织的DNA(用过的器皿和耗材需严格消毒),然后使用TaKaRa公司一步法PCR试剂盒操作如下:Take the respiratory papilloma tissue in a biological safety cabinet, grind and dilute, and extract the DNA of the tissue according to the instructions of the Omega DNA Extraction Kit (Cat. No.: D3096) (the used utensils and consumables must be strictly sterilized), and then use the one-step PCR method of TaKaRa Company The operation of the kit is as follows:
以DNA提取物为模板进行PCR扩增配制25μl体系,Use the DNA extract as a template for PCR amplification to prepare a 25 μl system,
2×1 step buffer (含dNTP) 13μL2×1 step buffer (including dNTP) 13μL
PrimeScript 1 Step Enzyme Mix 1μLPrimeScript 1 Step Enzyme Mix 1μL
上游引物(HPV11-5674-F) 0.5μLUpstream primer (HPV11-5674-F) 0.5 μL
下游引物(HPV11-6807-R) 0.5μLDownstream primer (HPV11-6807-R) 0.5 μL
DNA提取物(模版) 1μLDNA extract (template) 1 μL
DNAse Free dH2O 9μLDNAse Free dH2O 9μL
轻轻混匀、低速离心后置PCR自动扩增仪中,按照如下程序扩增:50℃ 30min,94℃2min一个循环→94℃ 30sec,52℃ 30sec,72℃ 45sec 35个循环。PCR产物用1%琼脂糖凝胶电泳纯化回收,利用T4连接酶与pMD-20-T Vector 16℃过夜连接,转化DH5α感受态细胞,挑单克隆斑于LB(Amp+)中扩大培养,用质粒提取试剂盒提纯质粒pMD-HPV11-L1,通过SpeI/EcoRI酶切鉴定,确定阳性质粒,见附图1。再通过测序鉴定,将成功构建的阳性质粒pMD-HPV11-L1大量提取后用EcoRI单酶切将其线性化,纯化测定浓度后于-80℃冻存。利用公式:(copies/μL)=[(ng数×10-9)×(6.02×1023) ]÷(碱基数×340)换算出目的DNA的拷贝数。Gently mix, centrifuge at low speed and place in a PCR automatic amplification instrument. Amplify according to the following program: 50°C for 30 minutes, 94°C for 2 minutes → 94°C for 30 sec, 52°C for 30 sec, 72°C for 45 sec for 35 cycles. The PCR product was purified and recovered by 1% agarose gel electrophoresis, ligated with pMD-20-T Vector overnight at 16°C with T4 ligase, transformed into DH5α competent cells, and single-clonal spots were picked and expanded in LB (Amp+). The plasmid pMD-HPV11-L1 was purified by the extraction kit, identified by SpeI/EcoRI digestion, and the positive plasmid was confirmed, as shown in Figure 1. After identification by sequencing, a large amount of the successfully constructed positive plasmid pMD-HPV11-L1 was extracted and linearized with EcoRI single enzyme digestion, purified and determined for concentration, and then frozen at -80°C. Use the formula: (copies/μL)=[(ng number×10 -9 )×(6.02×10 23 )]÷(base number×340) to convert the copy number of the target DNA.
三、标准曲线的建立3. Establishment of standard curve
根据定量后得到的拷贝数,将标准样品制成等6个梯度稀释的检测标准品,为降低误差,提高实验的可重复性,每个稀释度样品都设有三个重复孔,确定Ct值(Ct即cyclethreshold,指反应管中的荧光信号达到设定的阈值时的所经历的循环数),从而确定扩增效果最好的标准曲线。According to the copy number obtained after quantification, the standard sample was made into six serially diluted detection standard products. In order to reduce the error and improve the repeatability of the experiment, each dilution sample was provided with three replicate holes to determine the Ct value ( Ct is cyclethreshold, which refers to the number of cycles experienced when the fluorescent signal in the reaction tube reaches the set threshold), so as to determine the standard curve with the best amplification effect.
(1)荧光定量PCR扩增(1) Fluorescent quantitative PCR amplification
扩增体系为25μL,其中包含2×One Step RT-PCR BufferⅢ (含dNTP Mixture,Mg2+)、TaKaRa Ex Taq HS(5U/μL)、PrimeScript RT Enzyme MixⅡ、DNAse Free dH2O、上游引物SEQ1、下游引物SEQ2、探针SEQ3、和稀释好的标准品2μL。The amplification system is 25 μL, which contains 2×One Step RT-PCR Buffer Ⅲ (including dNTP Mixture, Mg2+), TaKaRa Ex Taq HS (5U/μL), PrimeScript RT Enzyme Mix Ⅱ, DNAse Free dH2O, upstream primer SEQ1, downstream primer SEQ2 , probe SEQ3, and 2 μL of diluted standard.
PCR扩增采用Agilent Techologies-Mx3005pPCR扩增仪,程序为:95℃ 10sec,1个循环(反转录)95℃ 10sec,55℃ 30sec,72℃30sec,40个循环(PCR扩增)Agilent Technologies-Mx3005p PCR amplifier was used for PCR amplification, and the program was: 95°C 10sec, 1 cycle (reverse transcription), 95°C 10sec, 55°C 30sec, 72°C 30sec, 40 cycles (PCR amplification)
其中荧光信号收集设置在每一循环的72℃30sec末。The fluorescent signal collection was set at the end of 30 sec at 72°C in each cycle.
(2)标准曲线的制备(2) Preparation of standard curve
PCR荧光信号的分析采用安捷伦公司MxPro软件,所得到的荧光定量PCR扩增曲线以及相应的标准曲线分别见附图2、3。The analysis of the PCR fluorescence signal was carried out by Agilent MxPro software, and the obtained fluorescence quantitative PCR amplification curve and the corresponding standard curve are shown in Figures 2 and 3, respectively.
四、特异性的检测4. Specific detection
用下属常见疫病病原:黏膜低危险型HPV6、黏膜高危险型HPV16、皮肤低危险型HPV1、皮肤高危险型HPV5,检测已建立方法的特异性,所得到的荧光定量PCR结果见附图4。结果显示该方法只能特异性的扩增出青少年复发性呼吸道乳头瘤HPV11亚型DNA阳性对照,特异性好。The following common disease pathogens: mucosal low-risk HPV6, mucosal high-risk HPV16, skin low-risk HPV1, and skin high-risk HPV5 were used to detect the specificity of the established method. The results obtained by fluorescent quantitative PCR are shown in Figure 4. The results show that this method can only specifically amplify the positive control of HPV11 subtype DNA of adolescent recurrent respiratory papilloma, and the specificity is good.
五、敏感性的检测5. Sensitivity detection
将标准样品制成1×108-1×101(copies/μL)8个稀释度,检测已建立方法的敏感性,所得到的荧光定量PCR结果见附图5。为确保检测的准确性,设置高压灭菌水为本底值对照,将≤34个循环的且曲线有明显的指数增长期的样品判定为阳性,此荧光定量检测方法能准确检测到约10个拷贝的病原,而普通PCR智能检测到1×104个拷贝,由此可见本发明的荧光定量PCR的检测敏感性是普通PCR的103倍,敏感性好。The standard sample was made into 8 dilutions of 1×10 8 -1×10 1 (copies/μL), and the sensitivity of the established method was tested. The obtained fluorescent quantitative PCR results are shown in Figure 5. In order to ensure the accuracy of the detection, high-pressure sterilized water is set as the background value control, and the samples with ≤34 cycles and the curve with obvious exponential growth period are judged as positive. This fluorescence quantitative detection method can accurately detect about 10 copies of pathogens, while ordinary PCR intelligently detects 1×10 4 copies, so it can be seen that the detection sensitivity of the fluorescent quantitative PCR of the present invention is 10 3 times that of ordinary PCR, and the sensitivity is good.
<110> 中国农业科学院兰州兽医研究所<110> Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
<120> 用于检测青少年复发性呼吸道乳头瘤状病毒的试剂盒<120> Kit for detection of recurrent respiratory papillomavirus in adolescents
<160> 5<160> 5
<210> 1<210> 1
<211> 18<211> 18
<212> DNA<212>DNA
<213> 人工序列(正向引物)<213> Artificial sequence (forward primer)
<400><400>
tcctcctaac cctgtatc 18tcctcctaac cctgtatc 18
<210> 2<210> 2
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列(反向引物)<213> Artificial sequence (reverse primer)
<400><400>
tgctggcatg ataaaatatg 20tgctggcatg ataaaatatg 20
<210> 3<210> 3
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列(探针引物)<213> Artificial sequence (probe primer)
<400><400>
cataagcatc cgtggcaaca actt 24cataagcatc cgtggcaaca actt 24
<210> 4<210> 4
<211> 26<211> 26
<212> DNA<212>DNA
<213> 人工序列(扩增L1基因的部分序列的上游引物 HPV11-5674-F)<213> Artificial sequence (upstream primer HPV11-5674-F to amplify partial sequence of L1 gene)
<400><400>
tggacgacca gctcttcctt aaacac 26tggacgacca gctcttcctt aaacac 26
<210> 5<210> 5
<211> 26<211> 26
<212> DNA<212>DNA
<213> 人工序列(扩增L1基因的部分序列的下游引物 HPV11-6807-R)<213> Artificial sequence (downstream primer HPV11-6807-R for amplifying partial sequence of L1 gene)
<400> agtgcaagtc tgggttgcag ccaaca 26<400> agtgcaagtc tgggttgcag ccaaca 26
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510035254.1A CN104651531B (en) | 2015-01-24 | 2015-01-24 | Kit for detecting juvenile recurrent respiratory papilloma virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510035254.1A CN104651531B (en) | 2015-01-24 | 2015-01-24 | Kit for detecting juvenile recurrent respiratory papilloma virus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104651531A CN104651531A (en) | 2015-05-27 |
CN104651531B true CN104651531B (en) | 2017-03-22 |
Family
ID=53243169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510035254.1A Active CN104651531B (en) | 2015-01-24 | 2015-01-24 | Kit for detecting juvenile recurrent respiratory papilloma virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104651531B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646705A (en) * | 2002-03-14 | 2005-07-27 | 类基因有限责任公司 | Amplification-hybridisation method for detecting and typing human papillomavirus |
CN102559932A (en) * | 2012-01-18 | 2012-07-11 | 泰普生物科学(中国)有限公司 | Kit for PCR (Polymerase Chain Reaction) detection of high-risk human papillomavirus (HPV) |
CN103290141A (en) * | 2013-01-29 | 2013-09-11 | 上海星耀医学科技发展有限公司 | Kit for detection of 16 high-risk and 5 low-risk HPV |
-
2015
- 2015-01-24 CN CN201510035254.1A patent/CN104651531B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646705A (en) * | 2002-03-14 | 2005-07-27 | 类基因有限责任公司 | Amplification-hybridisation method for detecting and typing human papillomavirus |
CN102559932A (en) * | 2012-01-18 | 2012-07-11 | 泰普生物科学(中国)有限公司 | Kit for PCR (Polymerase Chain Reaction) detection of high-risk human papillomavirus (HPV) |
CN103290141A (en) * | 2013-01-29 | 2013-09-11 | 上海星耀医学科技发展有限公司 | Kit for detection of 16 high-risk and 5 low-risk HPV |
Also Published As
Publication number | Publication date |
---|---|
CN104651531A (en) | 2015-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107299155B (en) | Primer and probe for real-time fluorescence quantitative PCR detection of goose astrovirus | |
CN111074000B (en) | A triple fluorescent quantitative PCR detection material and kit for distinguishing ASFV wild strains from double gene deletion strains | |
JP7374377B2 (en) | Test kit for Salmonella typhi, its manufacturing method, and its uses | |
CN111394431B (en) | Method for detecting nucleic acid by using double real-time fluorescent isothermal amplification technology | |
CN112538550B (en) | DHAV-1 and DHAV-3 detection system and application based on RT-RPA and CRISPR/Cas | |
CN103820573A (en) | Fluorescent quantitation PCR (polymerase chain reaction) detection kit for four conventional herpesvirus hominises | |
CN110567951A (en) | Visual detection system and detection method of apple stem groove virus based on CRISPR-Cas12a technology | |
CN105039585A (en) | Primer used in RT-PCR detection of chicken infectious bronchitis virus, kit comprising the primer and detection method thereof | |
CN113249522A (en) | Method for detecting SARS-CoV-2variant strain nucleic acid and its application | |
CN103031386A (en) | Triple fluorescent quantitative RT (Reverse Transcription)-PCR (Polymerase Chain Reaction) kit for detecting human calicivirus | |
CN108315483A (en) | A kind of combination for distinguishing the primer and probe of duck tembusu virus street strain and vaccine strain | |
CN107012237A (en) | A kind of fluorescence PCR method and kit of specific detection gondii nucleic acid | |
CN103820574B (en) | Human herpes virus type 6 real-time fluorescence quantitative PCR parting detecting reagent | |
CN112011650A (en) | Chinese bee sacbrood virus RT-RPA detection primer, probe and kit | |
CN116004908A (en) | Optimized SHERLOCK nucleic acid detection technology and application thereof in influenza A H1N1 virus detection | |
CN110205405B (en) | Kit, primer and probe for detecting and identifying O, A and Asial types of Seneca Valley virus, foot-and-mouth disease virus | |
CN116904667B (en) | Primer group, probe, kit and method for detecting wild strain and vaccine strain of porcine epidemic diarrhea virus | |
CN104450954B (en) | Detect the fluorescent PCR kit and its method of 13 kinds of hypotypes of human papilloma virus | |
Combrinck et al. | FRET-based detection and genotyping of HPV-6 and HPV-11 causing recurrent respiratory papillomatosis | |
CN104651531B (en) | Kit for detecting juvenile recurrent respiratory papilloma virus | |
CN107400735A (en) | Detect the real-time fluorescent quantitative RT-PCR method of zika virus | |
CN110643740A (en) | Real-time fluorescence quantitative RT-PCR detection primers, probes and detection kits for Paliam serogroup virus | |
CN113801961B (en) | rRT-RAA primer pair, probe, kit and application for detecting porcine sai virus A | |
CN101956024B (en) | Reagent for detecting human papillomavirus | |
CN107937615A (en) | For distinguishing the primer and probe of Latex agglutination test street strain and vaccine strain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |